Published in Science on December 14, 1990
Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci U S A (1992) 5.94
Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol (1992) 3.68
Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci U S A (1991) 3.45
Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol (1992) 3.37
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A (1992) 3.27
Increased activity of p53 in senescing fibroblasts. Proc Natl Acad Sci U S A (1995) 2.27
p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol (1993) 2.27
The p53 family: guardians of maternal reproduction. Nat Rev Mol Cell Biol (2011) 2.13
Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc Natl Acad Sci U S A (1998) 2.11
Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell (2001) 2.00
Inhibition of viral and cellular promoters by human wild-type p53. J Virol (1992) 1.83
Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet (1994) 1.80
Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol (1992) 1.57
A DNA binding domain is contained in the C-terminus of wild type p53 protein. Nucleic Acids Res (1991) 1.49
Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer (1992) 1.47
Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness. Am J Pathol (1994) 1.39
Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol Cell Biol (1993) 1.38
Human p53 inhibits growth in Schizosaccharomyces pombe. Mol Cell Biol (1992) 1.38
An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sci U S A (1992) 1.33
Ikaros induces quiescence and T-cell differentiation in a leukemia cell line. Mol Cell Biol (2005) 1.33
Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members. J Virol (2003) 1.31
Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors. Mol Cell Biol (1994) 1.30
Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol Cell Biol (1997) 1.28
The 1995 Walter Hubert Lecture--molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene. Br J Cancer (1996) 1.28
Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. J Virol (1998) 1.28
Tight DNA binding and oligomerization are dispensable for the ability of p53 to transactivate target genes and suppress transformation. EMBO J (1993) 1.25
The amino-terminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53-mediated growth arrest of cells. J Virol (1994) 1.22
The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene. Nucleic Acids Res (1993) 1.19
Nuclear protein phosphorylation and growth control. Biochem J (1992) 1.16
Tumourigenesis associated with the p53 tumour suppressor gene. Br J Cancer (1993) 1.16
A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs. Proc Natl Acad Sci U S A (1992) 1.16
Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. Proc Natl Acad Sci U S A (2000) 1.15
Interference with p53 protein inhibits hematopoietic and muscle differentiation. J Cell Biol (1996) 1.15
Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer (1993) 1.15
Increased p53 protein content of colorectal tumours correlates with poor survival. Br J Cancer (1992) 1.13
Repression of the basal c-fos promoter by wild-type p53. Nucleic Acids Res (1992) 1.13
Our changing view of the genomic landscape of cancer. J Pathol (2010) 1.13
The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. EMBO J (1993) 1.13
The ability of large T antigen to complex with p53 is necessary for the increased life span and partial transformation of human cells by simian virus 40. J Virol (1991) 1.11
DNA repair, genome stability and cancer: a historical perspective. Nat Rev Cancer (2015) 1.10
Analysis of a protein-binding domain of p53. Mol Cell Biol (1993) 1.10
Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway. J Exp Clin Cancer Res (2012) 1.08
The tumor suppressor p53 regulates its own transcription. Mol Cell Biol (1993) 1.08
A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells. Proc Natl Acad Sci U S A (1992) 1.06
p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol Cell Biol (1996) 1.06
Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma. Proc Natl Acad Sci U S A (1993) 1.05
Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas. Br J Cancer (1994) 1.03
Smoking, p53 mutation, and lung cancer. Mol Cancer Res (2014) 1.03
p53: the attractive tumor suppressor in the cancer research field. J Biomed Biotechnol (2010) 1.02
Modulation of cell proliferation and gene expression by a p53-estrogen receptor hybrid protein. Proc Natl Acad Sci U S A (1993) 1.01
Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma. Proc Natl Acad Sci U S A (1992) 0.98
p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53. EMBO J (1998) 0.98
Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis. Environ Health Perspect (1997) 0.96
p53 expression and K-ras mutation in colorectal adenomas. Gut (1993) 0.95
Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation. J Virol (1993) 0.95
Role of p53 in Cell Death and Human Cancers. Cancers (Basel) (2011) 0.95
Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes. Mol Cell Biol (1996) 0.94
Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding. J Virol (1991) 0.94
Caloric restriction: is mammalian life extension linked to p53? Aging (Albany NY) (2012) 0.94
A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat. Mol Cell Biol (1995) 0.92
p53 mutants have selective dominant-negative effects on apoptosis but not growth arrest in human cancer cell lines. Mol Cell Biol (2000) 0.92
Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest (1992) 0.90
Cancer risks from germline p53 mutations. J Clin Invest (1992) 0.89
Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity. Mech Ageing Dev (2007) 0.89
Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer (1996) 0.87
Adenovirus type 12-induced fragility of the human RNU2 locus requires p53 function. J Virol (1998) 0.86
N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes. Front Pharmacol (2014) 0.86
Long term growth arrest of human Tenon's fibroblasts following single applications of beta radiation. Br J Ophthalmol (1998) 0.86
Hot-spot p53 mutants interact specifically with two cellular proteins during progression of the cell cycle. Mol Cell Biol (1994) 0.86
Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein. Mol Cell Biol (1993) 0.86
p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice. J Virol (1992) 0.85
P53 protein in 204 patients with primary breast carcinoma--immunohistochemical detection and clinical value as a prognostic factor. Arch Gynecol Obstet (1995) 0.84
Mitochondrial genome instability resulting from SUV3 haploinsufficiency leads to tumorigenesis and shortened lifespan. Oncogene (2012) 0.84
Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses. Nucleic Acids Res (1992) 0.83
Cyclin E restores p53 activity in contact-inhibited cells. Mol Cell Biol (1995) 0.83
A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance. PLoS One (2015) 0.83
Wild-type p53 gene-induced morphological changes and growth suppression in hepatoma cells. J Gastroenterol (1997) 0.82
Molecular genetic aspects of human cancers: the 1993 Frank Rose Lecture. Br J Cancer (1993) 0.81
Highly specific antibody to Rous sarcoma virus src gene product recognizes nuclear and nucleolar antigens in human cells. J Virol (1995) 0.80
Analysis of p53, K-ras gene mutation & Helicobacter pylori infection in patients with gastric cancer & peptic ulcer disease at a tertiary care hospital in north India. Indian J Med Res (2012) 0.79
Mutation of the endogenous p53 gene in cells transformed by HPV-16 E7 and EJ c-ras confers a growth advantage involving an autocrine mechanism. EMBO J (1994) 0.79
Allelic imbalance on chromosome 5q predicts long-term survival in neuroblastoma. Br J Cancer (1996) 0.79
P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines. J Clin Invest (1993) 0.79
Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53. Br J Cancer (1998) 0.78
P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer. Br J Cancer (1996) 0.78
p53: a gene for all tumours? BMJ (1993) 0.77
Synergistic growth inhibition by combination of adenovirus mediated p53 transfer and cisplatin in ovarian cancer cell lines. J Gynecol Oncol (2009) 0.77
Ectopic expression of cdc2/cdc28 kinase subunit Homo sapiens 1 uncouples cyclin B metabolism from the mitotic spindle cell cycle checkpoint. Mol Cell Biol (1998) 0.77
Differentiation arrest and stromal cell-independent growth of murine erythroleukemia cells are associated with elevated expression of ets-related genes but not with mutation of p53. Mol Cell Biol (1993) 0.76
Pathogenic Mutations in Cancer-Predisposing Genes: A Survey of 300 Patients with Whole-Genome Sequencing and Lifetime Electronic Health Records. PLoS One (2016) 0.76
Liver disease. Postgrad Med J (1994) 0.76
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis. Transl Cancer Res (2016) 0.76
Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer. Int J Mol Sci (2017) 0.75
Comparison of effects of p53 null and gain-of-function mutations on salivary tumors in MMTV-Hras transgenic mice. PLoS One (2015) 0.75
Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers. Environ Health Perspect (1992) 0.75
The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev (1993) 17.09
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (1992) 8.16
Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (1987) 6.93
Heat shock proteins of higher plants. Proc Natl Acad Sci U S A (1981) 6.59
Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell (1989) 6.46
Physical and genetic characterization of the glnA--glnG region of the Escherichia coli chromosome. Proc Natl Acad Sci U S A (1981) 5.63
The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell (1991) 4.69
Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science (1988) 4.54
Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol (1994) 4.36
Characterization of a gene, glnL, the product of which is involved in the regulation of nitrogen utilization in Escherichia coli. J Bacteriol (1982) 4.19
Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science (1988) 4.15
SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell (1989) 3.88
The ability of some Yersinia enterocolitica strains to invade HeLa cells. Can J Microbiol (1977) 3.87
The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature (1987) 3.85
Aberrant subcellular localization of BRCA1 in breast cancer. Science (1995) 3.61
Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol (1992) 3.58
Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science (1990) 3.58
Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science (1999) 3.47
Improved Listeria monocytogenes selective agar. Appl Environ Microbiol (1986) 3.33
Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev (1996) 3.32
Interaction of mouse mammary epithelial cells with collagen substrata: regulation of casein gene expression and secretion. Proc Natl Acad Sci U S A (1985) 3.23
Fujinami sarcoma virus: an avian RNA tumor virus with a unique transforming gene. Proc Natl Acad Sci U S A (1980) 3.10
Expression and amplification of the N-myc gene in primary retinoblastoma. Nature (1984) 2.99
The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc Natl Acad Sci U S A (1998) 2.85
Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J (1991) 2.84
Development of USDA-FSIS method for isolation of Listeria monocytogenes from raw meat and poultry. J Assoc Off Anal Chem (1988) 2.73
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation (1986) 2.69
A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. Proc Natl Acad Sci U S A (1996) 2.54
Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature (2000) 2.44
Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev (1996) 2.32
PCR-based detection of a polymorphic BamHI site in intron 1 of the human retinoblastoma (RB) gene. Nucleic Acids Res (1990) 2.29
Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J (1990) 2.26
Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. Proc Natl Acad Sci U S A (1988) 2.22
Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene (1994) 2.20
Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice. Nat Biotechnol (1999) 2.20
Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome. Proc Natl Acad Sci U S A (1988) 2.20
Correlation of toxic and non-toxic strains of Clostridium botulinum by DNA composition and homology. J Gen Microbiol (1970) 2.08
The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein. Proc Natl Acad Sci U S A (1994) 2.06
BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res (1996) 2.04
Allergic rhinitis and risk of erectile dysfunction--a nationwide population-based study. Allergy (2013) 2.04
Expression of BRC repeats in breast cancer cells disrupts the BRCA2-Rad51 complex and leads to radiation hypersensitivity and loss of G(2)/M checkpoint control. J Biol Chem (1999) 2.04
Influence of substrate exposure history on biodegradation in a porous medium. J Contam Hydrol (2001) 2.03
Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev (1994) 1.99
Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology (2000) 1.96
C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc Natl Acad Sci U S A (1990) 1.91
Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. Mol Cell (2000) 1.91
HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis. Mol Cell Biol (1997) 1.90
The product of glnL is not essential for regulation of bacterial nitrogen assimilation. J Bacteriol (1983) 1.89
Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc Natl Acad Sci U S A (1996) 1.85
Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res (1998) 1.83
Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res (2001) 1.83
Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci U S A (1990) 1.82
The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing. J Cell Biol (1994) 1.80
Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med (1986) 1.79
The transcription factor E2F-1 mediates the autoregulation of RB gene expression. Mol Cell Biol (1994) 1.73
Updated gestational age specific birth weight, crown-heel length, and head circumference of Chinese newborns. Arch Dis Child Fetal Neonatal Ed (2003) 1.72
Non-small cell lung cancer in very young and very old patients. Chest (2000) 1.72
Enhancement of soybean RNA polymerase I by auxin. Proc Natl Acad Sci U S A (1975) 1.71
NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J Biol Chem (2000) 1.71
Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med (1987) 1.71
Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression. Mol Cell Biol (1995) 1.67
A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product. Nature (1991) 1.66
Phosphorylation of the nonstructural proteins encoded by three avian acute leukemia viruses and by avian fujinami sarcoma virus. J Virol (1980) 1.61
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol (2001) 1.60
Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J Biol Chem (1999) 1.57
BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc Natl Acad Sci U S A (2001) 1.56
Association of transfer RNA acceptor identity with a helical irregularity. Science (1988) 1.56
The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J Biol Chem (1996) 1.56
Molecular characterization of the retinoblastoma susceptibility gene. Biochim Biophys Acta (1993) 1.55
The retinoblastoma protein: more than a tumor suppressor. Annu Rev Cell Biol (1994) 1.54
Tumor suppressor genes: new prospects for cancer research. J Natl Cancer Inst (1991) 1.54
Association between simple anthropometric indices and cardiovascular risk factors. Int J Obes Relat Metab Disord (2001) 1.52
Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res (1998) 1.52
Treatment of intertrochanteric fracture with the Gamma AP locking nail or by a compression hip screw--a randomised prospective trial. Int Orthop (1998) 1.50
Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. Gastroenterology (1998) 1.47
Structure of the human retinoblastoma gene. Proc Natl Acad Sci U S A (1989) 1.44
Interaction of the nuclear matrix-associated region (MAR)-binding proteins, SATB1 and CDP/Cux, with a MAR element (L2a) in an upstream regulatory region of the mouse CD8a gene. J Biol Chem (1997) 1.43
Purification and characterization of RNA polymerase I from a higher plant. Biochim Biophys Acta (1976) 1.41
A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock. Mol Cell Biol (1996) 1.40
Evaluation of virulence test procedures for Yersinia enterocolitica recovered from foods. J Appl Bacteriol (1981) 1.39
Can intracatheter retention of antifungal agents cure fungal peritonitis? Two cases successfully treated without catheter removal. Perit Dial Int (1991) 1.38
Panencephalitic Creutzfeldt-Jakob disease. Unusual presentation of magnetic resonance imaging and proton magnetic resonance spectroscopy. J Neurol Sci (1996) 1.38
Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer (1994) 1.37
The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem (2000) 1.35
A class of soybean low molecular weight heat shock proteins : immunological study and quantitation. Plant Physiol (1992) 1.34
Lessons learned from BRCA1 and BRCA2. Oncogene (2000) 1.34
A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes. J Biol Chem (2001) 1.32
Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders. Nat Genet (1997) 1.32
Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med (1987) 1.31
A thyroid hormone receptor coactivator negatively regulated by the retinoblastoma protein. Proc Natl Acad Sci U S A (1997) 1.31
Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas. Oncogene Res (1989) 1.30
The genetic relatedness of proteolytic Clostridium botulinum strains. J Gen Microbiol (1970) 1.30
T cell lymphoma in transgenic mice expressing the human Hsp70 gene. Biochem Biophys Res Commun (1996) 1.30
Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc Natl Acad Sci U S A (1996) 1.29
Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics (1996) 1.29